Wall Street suffers its worst tech selloff in years. Anthropic loses $109B in value after IPO. October inflation data sets ...
Analyst rates Anthropic a Hold: a high-single-digit price-to-sales multiple implies fair value above $100, while AI ...
Analyst rates GDXY a cautious Hold: call spreads cushioned losses by only 4–5 points, while miner free cash flow could fall 2 ...
Analyst rates RISR a Buy: positive carry and negative duration could hedge tech and bonds, while lower inflation could make ...
Gencor Industries remains rated a ‘strong buy’ due to its compelling risk-reward profile and recent operational rebound. GENC ...
Structural forces are driving demand for robotics. Aging populations, operational challenges, and workplace safety needs ...
Seapeak's Series B preferred shares are an attractive option for investors. The high-yielding preferreds stand out among ...
Upgrading CG Oncology to Hold from Sell: Phase 3 success de-risks cretostimogene, but the valuation still demands exceptional ...
Analyst rates Oracle a high-risk Buy near $104, with a $188 12-month target tied to earnings delivery and multiple expansions ...
Li Ming is accused of helping smuggle restricted Nvidia AI chips into China; Novagate received at least $300 million in ...
Analyst rates Amerant Bancorp a cautious Buy: loan growth resumes, Q3 margin reaches 3.77%, and shares trade below 10x ...
Analyst rates Keurig Dr Pepper a Hold: its offering could dilute holders about 5%, and projected annual returns of 9.1%-11.1% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results